 | • レポートコード：20QY06-05240 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、経口血糖降下薬（OHAs）のグローバル市場について種類別（スルホニル尿素、メトホルミン、チアゾリジンジオン、アルファグルコシダーゼ阻害剤）、用途別（病院・診療所、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・経口血糖降下薬（OHAs）市場の概要 ・世界の主要地域別経口血糖降下薬（OHAs）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の経口血糖降下薬（OHAs）市場規模2015-2026：種類別（スルホニル尿素、メトホルミン、チアゾリジンジオン、アルファグルコシダーゼ阻害剤） ・世界の経口血糖降下薬（OHAs）市場規模2015-2026：用途別（病院・診療所、その他） ・経口血糖降下薬（OHAs）の北米市場規模2015-2020 ・経口血糖降下薬（OHAs）のヨーロッパ市場規模2015-2020 ・経口血糖降下薬（OHAs）の中国市場規模2015-2020 ・経口血糖降下薬（OHAs）の日本市場規模2015-2020 ・経口血糖降下薬（OHAs）の東南アジア市場規模2015-2020 ・経口血糖降下薬（OHAs）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、GlaxoSmithKline、Bayer、Bristol-Myers Squibb、Novonordisk、Sanofi-Aventis、Servier、Huadong Medicine、Wanbang Biopharmaceuticals、Double-Crane Pharmaceutical、Guangzhou Pharmaceutical） ・経口血糖降下薬（OHAs）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・経口血糖降下薬（OHAs）の市場動向・機会・課題 ・調査の結論 |
Oral hypoglycemic agents (OHAs) are a group of drugs used to help reduce the amount of sugar present in the blood. They are not insulin, but they stimulate the pancreas to produce insulin.
At present, China is a country with the most populous victims of diabetes, SO, China will witness a huge potential in the OHAS market.
Market Analysis and Insights: Global Oral Hypoglyceimic Agents (OHAs) Market
The global Oral Hypoglyceimic Agents (OHAs) market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Oral Hypoglyceimic Agents (OHAs) Scope and Market Size
The global Oral Hypoglyceimic Agents (OHAs) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oral Hypoglyceimic Agents (OHAs) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Oral Hypoglyceimic Agents (OHAs) market is segmented into
Sulfonylureas
Metformin
Thiazolidinediones
Alpha-Glucosidase Inhibitors
Segment by Application, the Oral Hypoglyceimic Agents (OHAs) market is segmented into
Hospitals and Clinics
Others
The Oral Hypoglyceimic Agents (OHAs) market is analysed and market size information is provided by regions (countries). Segment by Application, the Oral Hypoglyceimic Agents (OHAs) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Oral Hypoglyceimic Agents (OHAs) Market Share Analysis
Oral Hypoglyceimic Agents (OHAs) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Oral Hypoglyceimic Agents (OHAs) business, the date to enter into the Oral Hypoglyceimic Agents (OHAs) market, Oral Hypoglyceimic Agents (OHAs) product introduction, recent developments, etc.
The major vendors covered:
Pfizer
GlaxoSmithKline
Bayer
Bristol-Myers Squibb
Novonordisk
Sanofi-Aventis
Servier
Huadong Medicine
Wanbang Biopharmaceuticals
Double-Crane Pharmaceutical
Guangzhou Pharmaceutical
Table of Contents
1 Oral Hypoglyceimic Agents (OHAs) Market Overview
1.1 Oral Hypoglyceimic Agents (OHAs) Product Scope
1.2 Oral Hypoglyceimic Agents (OHAs) Segment by Type
1.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales by Type (2020-2026)
1.2.2 Sulfonylureas
1.2.3 Metformin
1.2.4 Thiazolidinediones
1.2.5 Alpha-Glucosidase Inhibitors
1.3 Oral Hypoglyceimic Agents (OHAs) Segment by Application
1.3.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Comparison by Application (2020-2026)
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Oral Hypoglyceimic Agents (OHAs) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Growth Rate (2015-2026)
1.4.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue and Growth Rate (2015-2026)
1.4.3 Global Oral Hypoglyceimic Agents (OHAs) Price Trends (2015-2026)
2 Oral Hypoglyceimic Agents (OHAs) Estimate and Forecast by Region
2.1 Global Oral Hypoglyceimic Agents (OHAs) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Oral Hypoglyceimic Agents (OHAs) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region (2015-2020)
2.2.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region (2015-2020)
2.3 Global Oral Hypoglyceimic Agents (OHAs) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
2.4.2 Europe Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
2.4.3 China Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
2.4.4 Japan Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
2.4.6 India Oral Hypoglyceimic Agents (OHAs) Estimates and Projections (2015-2026)
3 Global Oral Hypoglyceimic Agents (OHAs) Competition Landscape by Players
3.1 Global Top Oral Hypoglyceimic Agents (OHAs) Players by Sales (2015-2020)
3.2 Global Top Oral Hypoglyceimic Agents (OHAs) Players by Revenue (2015-2020)
3.3 Global Oral Hypoglyceimic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglyceimic Agents (OHAs) as of 2019)
3.4 Global Oral Hypoglyceimic Agents (OHAs) Average Price by Company (2015-2020)
3.5 Manufacturers Oral Hypoglyceimic Agents (OHAs) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Oral Hypoglyceimic Agents (OHAs) Players (Opinion Leaders)
4 Global Oral Hypoglyceimic Agents (OHAs) Market Size by Type
4.1 Global Oral Hypoglyceimic Agents (OHAs) Historic Market Review by Type (2015-2020)
4.1.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
4.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Type (2015-2020)
4.1.3 Global Oral Hypoglyceimic Agents (OHAs) Price by Type (2014-2020)
4.2 Global Oral Hypoglyceimic Agents (OHAs) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Type (2021-2026)
4.2.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Type (2021-2026)
4.2.3 Global Oral Hypoglyceimic Agents (OHAs) Price Forecast by Type (2021-2026)
5 Global Oral Hypoglyceimic Agents (OHAs) Market Size by Application
5.1 Global Oral Hypoglyceimic Agents (OHAs) Historic Market Review by Application (2015-2020)
5.1.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
5.1.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Application (2015-2020)
5.1.3 Global Oral Hypoglyceimic Agents (OHAs) Price by Application (2015-2020)
5.2 Global Oral Hypoglyceimic Agents (OHAs) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Oral Hypoglyceimic Agents (OHAs) Sales Forecast by Application (2021-2026)
5.2.2 Global Oral Hypoglyceimic Agents (OHAs) Revenue Forecast by Application (2021-2026)
5.2.3 Global Oral Hypoglyceimic Agents (OHAs) Price Forecast by Application (2021-2026)
3 North America Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
3.2 North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
3.3 North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
3.4 North America Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
4 Europe Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
4.2 Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
4.3 Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
4.4 Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
5 China Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
5.2 China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
5.3 China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
5.4 China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
6 Japan Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
6.2 Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
6.3 Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
6.4 Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
7 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
7.2 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
8 India Oral Hypoglyceimic Agents (OHAs) Market Facts & Figures
8.2 India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
8.3 India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
8.4 India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Oral Hypoglyceimic Agents (OHAs) Business
12.1 Pfizer
12.1.1 Pfizer Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.1.2 Pfizer Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.1.3 Pfizer Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Oral Hypoglyceimic Agents (OHAs) Products Offered
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.2.2 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.2.3 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Products Offered
12.2.5 GlaxoSmithKline Recent Development
12.3 Bayer
12.3.1 Bayer Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.3.2 Bayer Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.3.3 Bayer Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Oral Hypoglyceimic Agents (OHAs) Products Offered
12.3.5 Bayer Recent Development
12.4 Bristol-Myers Squibb
12.4.1 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.4.2 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.4.3 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Products Offered
12.4.5 Bristol-Myers Squibb Recent Development
12.5 Novonordisk
12.5.1 Novonordisk Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.5.2 Novonordisk Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.5.3 Novonordisk Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novonordisk Oral Hypoglyceimic Agents (OHAs) Products Offered
12.5.5 Novonordisk Recent Development
12.6 Sanofi-Aventis
12.6.1 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.6.2 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.6.3 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Products Offered
12.6.5 Sanofi-Aventis Recent Development
12.7 Servier
12.7.1 Servier Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.7.2 Servier Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.7.3 Servier Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Servier Oral Hypoglyceimic Agents (OHAs) Products Offered
12.7.5 Servier Recent Development
12.8 Huadong Medicine
12.8.1 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.8.2 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.8.3 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Products Offered
12.8.5 Huadong Medicine Recent Development
12.9 Wanbang Biopharmaceuticals
12.9.1 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.9.2 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.9.3 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Products Offered
12.9.5 Wanbang Biopharmaceuticals Recent Development
12.10 Double-Crane Pharmaceutical
12.10.1 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.10.2 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.10.3 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Products Offered
12.10.5 Double-Crane Pharmaceutical Recent Development
12.11 Guangzhou Pharmaceutical
12.11.1 Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Corporation Information
12.11.2 Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Business Overview and Total Revenue
12.11.3 Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Products Offered
12.11.5 Guangzhou Pharmaceutical Recent Development
13 Oral Hypoglyceimic Agents (OHAs) Manufacturing Cost Analysis
13.1 Oral Hypoglyceimic Agents (OHAs) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Oral Hypoglyceimic Agents (OHAs)
13.4 Oral Hypoglyceimic Agents (OHAs) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Oral Hypoglyceimic Agents (OHAs) Distributors List
14.3 Oral Hypoglyceimic Agents (OHAs) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) Comparison by Application (2020-2026)
Table 3. Global Market Oral Hypoglyceimic Agents (OHAs) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Region (2015-2020)
Table 5. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Region (2015-2020)
Table 6. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Region (2015-2020)
Table 8. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Oral Hypoglyceimic Agents (OHAs) (K MT) of Key Companies (2015-2020)
Table 13. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Company (2015-2020)
Table 14. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Company (2015-2020)
Table 16. Global Oral Hypoglyceimic Agents (OHAs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oral Hypoglyceimic Agents (OHAs) as of 2019)
Table 17. Global Oral Hypoglyceimic Agents (OHAs) Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Oral Hypoglyceimic Agents (OHAs) Manufacturing Sites and Area Served
Table 19. Manufacturers Oral Hypoglyceimic Agents (OHAs) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Oral Hypoglyceimic Agents (OHAs) Players
Table 22. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 23. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Type (2015-2020)
Table 24. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Oral Hypoglyceimic Agents (OHAs) Price (K MT) by Type (2015-2020)
Table 26. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Type (2021-2026)
Table 27. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Type (2021-2026)
Table 29. Global Oral Hypoglyceimic Agents (OHAs) Price (K MT) by Type (2021-2026)
Table 30. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 31. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Application (2015-2020)
Table 32. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Oral Hypoglyceimic Agents (OHAs) Price (K MT) by Application (2015-2020)
Table 34. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2021-2026)
Table 35. Global Oral Hypoglyceimic Agents (OHAs) Sales Share by Application (2021-2026)
Table 36. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Application (2021-2026)
Table 38. Global Oral Hypoglyceimic Agents (OHAs) Price (K MT) by Application (2021-2026)
Table 39. United States Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 40. United States Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 41. United States Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 42. United States Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 43. United States Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 44. United States Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 45. Europe Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 46. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 47. Europe Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 48. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 49. Europe Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 50. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 51. China Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 52. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 53. China Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 54. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 55. China Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 56. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 57. Japan Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 58. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 59. Japan Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 60. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 61. Japan Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 62. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 69. India Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Company (2015-2020)
Table 70. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company (2015-2020)
Table 71. India Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Type (2015-2020)
Table 72. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type (2015-2020)
Table 73. India Oral Hypoglyceimic Agents (OHAs) Sales (K MT) by Application (2015-2020)
Table 74. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Oral Hypoglyceimic Agents (OHAs) Product
Table 79. Pfizer Recent Development
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. GlaxoSmithKline Oral Hypoglyceimic Agents (OHAs) Product
Table 84. GlaxoSmithKline Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Bayer Oral Hypoglyceimic Agents (OHAs) Product
Table 89. Bayer Recent Development
Table 90. Bristol-Myers Squibb Corporation Information
Table 91. Bristol-Myers Squibb Description and Business Overview
Table 92. Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Bristol-Myers Squibb Oral Hypoglyceimic Agents (OHAs) Product
Table 94. Bristol-Myers Squibb Recent Development
Table 95. Novonordisk Corporation Information
Table 96. Novonordisk Description and Business Overview
Table 97. Novonordisk Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Novonordisk Oral Hypoglyceimic Agents (OHAs) Product
Table 99. Novonordisk Recent Development
Table 100. Sanofi-Aventis Corporation Information
Table 101. Sanofi-Aventis Description and Business Overview
Table 102. Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sanofi-Aventis Oral Hypoglyceimic Agents (OHAs) Product
Table 104. Sanofi-Aventis Recent Development
Table 105. Servier Corporation Information
Table 106. Servier Description and Business Overview
Table 107. Servier Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Servier Oral Hypoglyceimic Agents (OHAs) Product
Table 109. Servier Recent Development
Table 110. Huadong Medicine Corporation Information
Table 111. Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Huadong Medicine Description and Business Overview
Table 113. Huadong Medicine Oral Hypoglyceimic Agents (OHAs) Product
Table 114. Huadong Medicine Recent Development
Table 115. Wanbang Biopharmaceuticals Corporation Information
Table 116. Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Wanbang Biopharmaceuticals Description and Business Overview
Table 118. Wanbang Biopharmaceuticals Oral Hypoglyceimic Agents (OHAs) Product
Table 119. Wanbang Biopharmaceuticals Recent Development
Table 120. Double-Crane Pharmaceutical Corporation Information
Table 121. Double-Crane Pharmaceutical Description and Business Overview
Table 122. Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Double-Crane Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Product
Table 124. Double-Crane Pharmaceutical Recent Development
Table 125. Guangzhou Pharmaceutical Corporation Information
Table 126. Guangzhou Pharmaceutical Description and Business Overview
Table 127. Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Guangzhou Pharmaceutical Oral Hypoglyceimic Agents (OHAs) Product
Table 129. Guangzhou Pharmaceutical Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Oral Hypoglyceimic Agents (OHAs) Distributors List
Table 133. Oral Hypoglyceimic Agents (OHAs) Customers List
Table 134. Market Key Trends
Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 136. Key Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Hypoglyceimic Agents (OHAs) Product Picture
Figure 2. Global Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Oral Hypoglyceimic Agents (OHAs) Market Share by Application in 2020 & 2026
Figure 6. Hospitals and Clinics Examples
Figure 7. Others Examples
Figure 8. Global Oral Hypoglyceimic Agents (OHAs) Sales (K MT) Growth Rate (2015-2026)
Figure 9. Global Oral Hypoglyceimic Agents (OHAs) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Oral Hypoglyceimic Agents (OHAs) Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 11. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Oral Hypoglyceimic Agents (OHAs) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Oral Hypoglyceimic Agents (OHAs) Sales (K MT) Growth Rate (2015-2026)
Figure 15. Europe Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Oral Hypoglyceimic Agents (OHAs) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Oral Hypoglyceimic Agents (OHAs) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Oral Hypoglyceimic Agents (OHAs) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Oral Hypoglyceimic Agents (OHAs) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Oral Hypoglyceimic Agents (OHAs) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Oral Hypoglyceimic Agents (OHAs) Players Market Share by Revenue in Oral Hypoglyceimic Agents (OHAs) 2015 & 2019
Figure 26. Oral Hypoglyceimic Agents (OHAs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Type (2015-2020)
Figure 28. Global Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Oral Hypoglyceimic Agents (OHAs) Revenue Share by Application (2015-2020)
Figure 30. Global Oral Hypoglyceimic Agents (OHAs) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 32. United States Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 33. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company in 2019
Figure 34. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 35. Europe Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 36. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company in 2019
Figure 37. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 38. China Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 39. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company in 2019
Figure 40. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 41. Japan Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 45. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Company in 2019
Figure 46. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Type in 2019
Figure 47. India Oral Hypoglyceimic Agents (OHAs) Sales Market Share by Application in 2019
Figure 48. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novonordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Servier Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Huadong Medicine Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Wanbang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Double-Crane Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Guangzhou Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Key Raw Materials Price Trend
Figure 60. Manufacturing Cost Structure of Oral Hypoglyceimic Agents (OHAs)
Figure 61. Manufacturing Process Analysis of Oral Hypoglyceimic Agents (OHAs)
Figure 62. Oral Hypoglyceimic Agents (OHAs) Industrial Chain Analysis
Figure 63. Channels of Distribution
Figure 64. Distributors Profiles
Figure 65. Porter's Five Forces Analysis
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
経口血糖降下薬（OHA）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Hypoglyceimic Agents (OHAs) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oral Hypogly…- 経口血糖降下薬及びインスリン類似体の世界市場レポート2020 QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients. Report Overview: The global Oral Hypoglycemic Agents and I…
- 鎮痙及び抗コリンH2遮断薬の世界市場レポート2020 A recently published report by QY Research titled Global Antispasmodic and Anticholinergic H2 Blocking Agents Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report al…
- 脱墨剤の世界市場レポート2020 Deinking agents is to reduce the waste paper and printing ink of surface tension and produce saponification, wetting, penetration, emulsification, decentralized and bleaching Mosaic. Market Analysis and Insights: Global Deinking Agents Market The global Deinking Agents market was valued at US$ xx mi…
- 経口セファロスポリンの世界市場レポート2020 Market Analysis and Insights: Global Oral Cephalosporin Market The global Oral Cephalosporin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Oral Cephalosporin Scope and Market Size The global Oral Cephal…